# Toppoint Holdings Inc.: financial statements, quarterly

TOPP · NYSE · CIK 1960847 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/topp.md) · [Financials](/companies/topp/financials.md) · [Filings](/companies/topp/filings.md) · [Insiders](/companies/topp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/topp/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,734](/filings/0001213900-25-044274.md) | [4,697](/filings/0001213900-25-076782.md) | [3,737](/filings/0001213900-25-110927.md) | [3,872 d](/filings/0001213900-26-034067.md) | [3,812](/filings/0001213900-26-056650.md) | [3,969](/filings/0001213900-26-088349.md) | [4,495](/filings/0001213900-25-110927.md) | [4,273 d](/filings/0001213900-26-034067.md) | [4,107](/filings/0001213900-26-056650.md) | [4,640](/filings/0001213900-26-088349.md) |
| Cost of revenue | $k | [3,255](/filings/0001213900-25-044274.md) | [3,844](/filings/0001213900-25-076782.md) | [3,279](/filings/0001213900-25-110927.md) | [3,323 d](/filings/0001213900-25-032145.md) | [3,314](/filings/0001213900-25-044274.md) | [3,514](/filings/0001213900-25-076782.md) | [3,124](/filings/0001213900-25-110927.md) | [6,100 d](/filings/0001213900-26-034067.md) | [4,274](/filings/0001213900-26-056650.md) | [4,263](/filings/0001213900-26-088349.md) |
| Selling, general and administrative | $k | not reported | [647](/filings/0001213900-25-076782.md) | [893](/filings/0001213900-25-110927.md) | [428 d](/filings/0001213900-26-034067.md) | [517](/filings/0001213900-26-056650.md) | [2,044](/filings/0001213900-25-076782.md) | [5,601](/filings/0001213900-25-110927.md) | [(675) d](/filings/0001213900-26-034067.md) | [547](/filings/0001213900-26-056650.md) | not reported |
| Operating income | $k | [148](/filings/0001213900-25-044274.md) | [206](/filings/0001213900-25-076782.md) | [(435)](/filings/0001213900-25-110927.md) | [(565) d](/filings/0001213900-26-034067.md) | [(407)](/filings/0001213900-26-056650.md) | [(1,589)](/filings/0001213900-26-088349.md) | [(4,230)](/filings/0001213900-25-110927.md) | [(1,152) d](/filings/0001213900-26-034067.md) | [(714)](/filings/0001213900-26-056650.md) | [(341)](/filings/0001213900-26-088349.md) |
| Interest expense | $k | [1.4](/filings/0001213900-25-044274.md) | [1.4](/filings/0001213900-25-076782.md) | [56.7](/filings/0001213900-25-110927.md) | [80.2 d](/filings/0001213900-26-034067.md) | [100](/filings/0001213900-26-056650.md) | [152](/filings/0001213900-26-088349.md) | [31.8](/filings/0001213900-25-110927.md) | [79.6 d](/filings/0001213900-26-034067.md) | [27.2](/filings/0001213900-26-056650.md) | [54.6](/filings/0001213900-26-088349.md) |
| Income tax | $k | [35.4](/filings/0001213900-25-044274.md) | [60.6](/filings/0001213900-25-076782.md) | [0.1](/filings/0001213900-25-110927.md) | [(206) d](/filings/0001213900-26-034067.md) | [93.7](/filings/0001213900-26-056650.md) | [(109)](/filings/0001213900-26-088349.md) | [0.0 d](/filings/0001213900-25-110927.md) | [0.0 d](/filings/0001213900-26-034067.md) | not reported | not reported |
| Net income | $k | [111](/filings/0001213900-25-076782.md) | [144](/filings/0001213900-25-076782.md) | [(27.5)](/filings/0001213900-25-110927.md) | [(52.8) d](/filings/0001213900-26-034067.md) | [(528)](/filings/0001213900-26-088349.md) | [(1,532)](/filings/0001213900-26-088349.md) | [(4,147)](/filings/0001213900-25-110927.md) | [(1,138) d](/filings/0001213900-26-034067.md) | [(654)](/filings/0001213900-26-088349.md) | [(307)](/filings/0001213900-26-088349.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001213900-25-044274.md) | [0.01](/filings/0001213900-25-076782.md) | [0.00](/filings/0001213900-25-110927.md) | not reported | [(0.03)](/filings/0001213900-26-056650.md) | [(0.09)](/filings/0001213900-26-088349.md) | [(0.23)](/filings/0001213900-25-110927.md) | not reported | [(0.03)](/filings/0001213900-26-056650.md) | [(0.01)](/filings/0001213900-26-088349.md) |
| Basic EPS | $ per share | [0.01](/filings/0001213900-25-044274.md) | [0.01](/filings/0001213900-25-076782.md) | [0.00](/filings/0001213900-25-110927.md) | not reported | [(0.03)](/filings/0001213900-26-056650.md) | [(0.09)](/filings/0001213900-26-088349.md) | [(0.23)](/filings/0001213900-25-110927.md) | not reported | [(0.03)](/filings/0001213900-26-056650.md) | [(0.01)](/filings/0001213900-26-088349.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [1.5](/filings/0001213900-25-032145.md) | not reported | not reported | not reported | [0.6](/filings/0001213900-26-034067.md) | [1.7](/filings/0001213900-25-044274.md) | [1.5](/filings/0001213900-25-076782.md) | [0.5](/filings/0001213900-25-110927.md) | [1.2](/filings/0001213900-26-034067.md) | [0.8](/filings/0001213900-26-056650.md) | [4.7](/filings/0001213900-26-088349.md) |
| Current assets | $m | not reported | [2.8](/filings/0001213900-25-032145.md) | not reported | not reported | not reported | [2.2](/filings/0001213900-26-034067.md) | [3.4](/filings/0001213900-25-044274.md) | [3.2](/filings/0001213900-25-076782.md) | [2.4](/filings/0001213900-25-110927.md) | [5.2](/filings/0001213900-26-088349.md) | [5.1](/filings/0001213900-26-056650.md) | [9.0](/filings/0001213900-26-088349.md) |
| Total assets | $m | not reported | [5.0](/filings/0001213900-25-032145.md) | not reported | not reported | not reported | [5.0](/filings/0001213900-26-034067.md) | [12.5](/filings/0001213900-25-044274.md) | [12.3](/filings/0001213900-25-076782.md) | [10.7](/filings/0001213900-25-110927.md) | [11.0](/filings/0001213900-26-088349.md) | [10.3](/filings/0001213900-26-056650.md) | [13.9](/filings/0001213900-26-088349.md) |
| Current liabilities | $m | not reported | [1.6](/filings/0001213900-25-032145.md) | not reported | not reported | not reported | [1.8](/filings/0001213900-26-034067.md) | [1.8](/filings/0001213900-25-044274.md) | [2.0](/filings/0001213900-25-076782.md) | [0.9](/filings/0001213900-25-110927.md) | [1.6](/filings/0001213900-26-088349.md) | [1.6](/filings/0001213900-26-056650.md) | [1.6](/filings/0001213900-26-088349.md) |
| Total liabilities | $m | not reported | [2.6](/filings/0001213900-25-032145.md) | not reported | not reported | not reported | [2.4](/filings/0001213900-26-034067.md) | [2.4](/filings/0001213900-25-044274.md) | [2.7](/filings/0001213900-25-076782.md) | [1.5](/filings/0001213900-25-110927.md) | [2.4](/filings/0001213900-26-088349.md) | [2.3](/filings/0001213900-26-056650.md) | [2.1](/filings/0001213900-26-088349.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001213900-25-032145.md) | [0.1](/filings/0001213900-25-044274.md) | [0.5](/filings/0001213900-25-076782.md) | [0.5](/filings/0001213900-25-110927.md) | [1.0](/filings/0001213900-26-088349.md) | [1.0](/filings/0001213900-26-056650.md) | [0.9](/filings/0001213900-26-088349.md) |
| Shareholders' equity | $m | [1.8](/filings/0001213900-25-032145.md) | [2.4](/filings/0001213900-26-034067.md) | [2.5](/filings/0001213900-25-076782.md) | [2.6](/filings/0001213900-25-110927.md) | [2.6](/filings/0001213900-25-110927.md) | [2.5](/filings/0001213900-26-088349.md) | [10.1](/filings/0001213900-26-088349.md) | [9.5](/filings/0001213900-26-088349.md) | [9.2](/filings/0001213900-25-110927.md) | [8.6](/filings/0001213900-26-088349.md) | [8.0](/filings/0001213900-26-088349.md) | [11.8](/filings/0001213900-26-088349.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [15.7](/filings/0001213900-25-044274.md) | [(193) d](/filings/0001213900-25-076782.md) | [(636) d](/filings/0001213900-25-110927.md) | [219 d](/filings/0001213900-26-034067.md) | [(884)](/filings/0001213900-26-056650.md) | [(255) d](/filings/0001213900-26-088349.md) | [(445) d](/filings/0001213900-25-110927.md) | [(197) d](/filings/0001213900-26-034067.md) | [(791)](/filings/0001213900-26-056650.md) | [(128) d](/filings/0001213900-26-088349.md) |
| Capital expenditure | $k | not reported | not reported | [5.9 d](/filings/0001213900-25-110927.md) | [1,165 d](/filings/0001213900-26-034067.md) | [693](/filings/0001213900-26-056650.md) | [320 d](/filings/0001213900-26-088349.md) | [0.0 d](/filings/0001213900-25-110927.md) | [(658) d](/filings/0001213900-26-034067.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.0](/filings/0001213900-25-044274.md) | [15.0](/filings/0001213900-25-076782.md) | [15.0](/filings/0001213900-25-110927.md) | [16.9](/filings/0001213900-26-056650.md) | [17.5](/filings/0001213900-26-088349.md) | [17.8](/filings/0001213900-25-110927.md) | [19.7](/filings/0001213900-26-056650.md) | [21.0](/filings/0001213900-26-088349.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,700,000 at 2026-08-11, from the cover of the [10-Q filed 2026-08-12](/filings/0001213900-26-088349.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.